Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | $0.73 | $0.98 | $0.85 |
| Q2 2026 | 1 | $1.31 | $1.64 | $1.44 |
| Q3 2026 | 1 | $1.40 | $1.74 | $1.53 |
| Q4 2026 | 1 | $0.81 | $1.01 | $0.89 |
| Q1 2027 | 1 | $0.99 | $1.23 | $1.08 |
| Q2 2027 | 1 | $1.96 | $2.44 | $2.14 |
| Q3 2027 | 1 | $1.88 | $2.35 | $2.06 |
| Q4 2027 | 1 | $1.17 | $1.46 | $1.28 |
Ingevity Corp last posted its earnings results on Wednesday, November 5th, 2025. The company reported $1.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.63. The company had revenue of 333.10 M for the quarter and had revenue of 1.41 B for the year. Ingevity Corp has generated $-12 earnings per share over the last year ($-11.85 diluted earnings per share) and currently has a price-to-earnings ratio of -39.66. Ingevity Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/06/2025 | Q3 2025 | N/A | $1.20 | N/A | $360.43 M | $333.10 M |
| 08/05/2025 | Q2 2025 | N/A | -$4.02 | N/A | $378.70 M | $365.10 M |
| 05/06/2025 | Q1 2025 | N/A | $0.56 | N/A | N/A | $284.00 M |
| 02/19/2025 | Q4 2024 | N/A | $0.46 | N/A | N/A | $298.80 M |
| 10/30/2024 | Q3 2024 | N/A | -$2.95 | N/A | $376.95 M | $376.90 M |
| 08/01/2024 | Q2 2024 | N/A | -$7.81 | N/A | $407.58 M | $390.60 M |
| 05/02/2024 | Q1 2024 | N/A | -$1.54 | N/A | N/A | $340.10 M |
| 02/22/2024 | Q4 2023 | N/A | -$3.23 | N/A | N/A | $371.70 M |
| 11/02/2023 | Q3 2023 | N/A | $0.70 | N/A | N/A | $446.00 M |
| 08/03/2023 | Q2 2023 | N/A | $0.98 | N/A | N/A | $482.10 M |
| 05/04/2023 | Q1 2023 | N/A | $1.36 | N/A | N/A | $392.60 M |
| 02/28/2023 | Q4 2022 | N/A | $0.42 | N/A | N/A | $383.60 M |
| 11/03/2022 | Q3 2022 | N/A | $1.99 | N/A | N/A | $482.80 M |
| 08/03/2022 | Q2 2022 | N/A | $1.55 | N/A | N/A | $419.90 M |
| 05/05/2022 | Q1 2022 | N/A | $1.56 | N/A | N/A | $383.00 M |
| 02/24/2022 | Q4 2021 | N/A | $0.74 | N/A | N/A | $336.10 M |
| 10/28/2021 | Q3 2021 | N/A | -$0.11 | N/A | N/A | $376.80 M |
| 07/29/2021 | Q2 2021 | N/A | $1.11 | N/A | N/A | $358.40 M |
| 04/29/2021 | Q1 2021 | N/A | $1.21 | N/A | N/A | $320.30 M |
| 02/19/2021 | Q4 2020 | N/A | $1.24 | N/A | N/A | $325.60 M |
In the previous quarter, Ingevity Corp (:NGVT) reported $1.31 earnings per share (EPS) to beat the analysts' consensus estimate of $0.68 by $0.63.
The conference call for Ingevity Corp's latest earnings report can be listened to online.
The conference call transcript for Ingevity Corp's latest earnings report can be read online.
Ingevity Corp (:NGVT) has a recorded annual revenue of $1.41 B.
Ingevity Corp (:NGVT) has a recorded net income of $-430,300,000.Ingevity Corp has generated $-11.85 earnings per share over the last four quarters.
Ingevity Corp (:NGVT) has a price-to-earnings ratio of -39.66 and price/earnings-to-growth ratio is -0.57.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED